focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.175
Bid: 26.45
Ask: 27.90
Change: 0.975 (3.72%)
Spread: 1.45 (5.482%)
Open: 26.20
High: 0.00
Low: 0.00
Prev. Close: 26.20
REVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event and FY24 Trading Update

8 Feb 2024 07:00

RNS Number : 4075C
Revolution Beauty Group PLC
08 February 2024

8 February 2024


Revolution Beauty Group plc


("Revolution Beauty", the "Group", or the "Company")


Capital Markets Event and FY24 Trading Update


New leadership team outlines strategy to accelerate profitable growth

and ambition to deliver retail brand sales of £1 billion by 2030


Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, will today hold a Capital Markets Event for institutional investors and sell-side analysts. The Group is also providing a brief trading update for the 2024 financial year.


Capital Markets Event - Reigniting the Revolution

Hosted by Lauren Brindley, CEO, Neil Catto, CFO, Alison Hollingsworth, CMO and Stephen Vanoli, COO, the event will outline management's plans to transform the business and accelerate growth, with an ambition to drive annual retail brand sales of £1 billion by 2030, establishing Revolution Beauty as a top five mass beauty player globally.


The Group's "Reigniting the Revolution" strategy is being implemented to deliver long-term profitable growth in an attractive global beauty market, where Revolution Beauty has significant headroom to expand. The strategy is built on three key pillars:


· Driving the Masterbrand: Focusing investment on the REVOLUTION brand, leveraging its significant brand equity;


· Powering core categories: Significantly reducing the Group's number of SKUs and concentrating on the development of key products, whilst being first to market with innovation; and


· Focussed global growth: Managing distribution and retail partnerships to maximise returns, with a particular focus on gaining market share in the US.


This strategy is underpinned by three enablers: Team Revolution: building the most capable and motivated global team; Smart Operations: ensuring the best customer service, driven by effective inventory management and supply chain optimisation; and Fuel the Revolution: self-funding investments to drive growth through a profitable operating model, efficient balance sheet and cash management, and cost savings programmes. Management expects to deliver £10 million of cost savings over the next three years, which will be used to invest in future growth initiatives.


Trading Update

At the time of its half year results announcement in November 2023, Revolution Beauty expected to deliver adjusted EBITDA of not less than double-digits and high single digit revenue growth for the 2024 financial year.


As noted above, the Group has accelerated the rationalisation of lower margin SKUs, successfully driving margin improvement. As a result of this greater focus, FY24 adjusted EBITDA is now expected to be between £11 million and £12 million, and revenue growth is expected to be in the low single digits.


The Group has also signed a 12-month extension to its £32 million Revolving Credit Facility (RCF). The RCF will now run until October 2025 on unchanged terms.


Lauren Brindley, Group Chief Executive Officer, said:

"Revolution Beauty is a business with unique capabilities, a loyal Gen Z customer base and relationships with some of the world's best beauty retailers. The strategy that we're setting out today is about harnessing our strengths and taking the brand back to its roots. We want to build on what we're best known for - our innovation, speed to market, accessibility and inclusivity.


"By focusing on our Revolution Masterbrand, building smarter operations, maintaining financial discipline and energising our teams, we believe we will deliver long-term profitable growth.


"We are confident we can achieve our ambition to deliver annual retail brand sales of £1 billion by 2030, establishing Revolution Beauty as a top five mass beauty brand globally."



A recording will be made available on the Investor Relations section of the Group's website following the event at:




For further information please contact:


Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO


Joint Corporate Brokers

Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222


Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512


Media enquiries

Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Date   Source Headline
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report
4th Sep 20235:30 pmRNSHolding(s) in Company
4th Sep 20235:27 pmRNSHolding(s) in Company
31st Aug 20238:32 amRNSDirectorate Changes
21st Aug 20237:00 amRNSNotice of Results
7th Aug 202312:45 pmRNSGeneral Meeting Indefinitely Adjourned
24th Jul 20234:22 pmRNSHolding(s) in Company
21st Jul 20234:57 pmRNSRegulatory Investigation
21st Jul 20231:43 pmRNSPDMR Dealing
21st Jul 202310:58 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSWithdrawal of GM requisition & Board Updates
18th Jul 20237:00 amRNSSettlement Agreement with boohoo
10th Jul 20234:49 pmRNSNotice of General Meeting
5th Jul 202310:37 amRNSChange of registered office address
4th Jul 20232:09 pmRNSDirector dealings
3rd Jul 20234:30 pmRNSDirector dealings
30th Jun 20237:00 amRNSResponse to boohoo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.